标题
Targeting Angiogenesis in Biliary Tract Cancers: An Open Option
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 2, Pages 418
出版商
MDPI AG
发表日期
2017-02-15
DOI
10.3390/ijms18020418
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cholangiocarcinoma: Current Knowledge and New Developments
- (2017) Boris Blechacz Gut and Liver
- Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) J. W. Valle et al. ANNALS OF ONCOLOGY
- Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma
- (2016) Kulthida Vaeteewoottacharn et al. TUMOR BIOLOGY
- Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma
- (2016) Giuliana Cavalloni et al. Oncotarget
- YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
- (2015) Patricia Marti et al. HEPATOLOGY
- Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers
- (2015) Elizabeth R. Kessler et al. INVESTIGATIONAL NEW DRUGS
- Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data
- (2015) Lorenzo Fornaro et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial
- (2015) Juan W Valle et al. LANCET ONCOLOGY
- Genomic spectra of biliary tract cancer
- (2015) Hiromi Nakamura et al. NATURE GENETICS
- FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma
- (2015) Jean-Florian Guion-Dusserre et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma
- (2015) Qingbao Cheng et al. Scientific Reports
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study
- (2014) A. Santoro et al. ANNALS OF ONCOLOGY
- Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumours
- (2014) N Dey et al. BRITISH JOURNAL OF CANCER
- S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma
- (2014) A B El-Khoueiry et al. BRITISH JOURNAL OF CANCER
- Tumor necrosis factor-α promotes the lymphangiogenesis of gallbladder carcinoma through nuclear factor-κB-mediated upregulation of vascular endothelial growth factor-C
- (2014) Qiang Du et al. CANCER SCIENCE
- Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme
- (2014) M. Moehler et al. EUROPEAN JOURNAL OF CANCER
- Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment
- (2014) Afsaneh Barzi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Axitinib (AG-013736), an Oral Specific VEGFR TKI, Shows Potential Therapeutic Utility Against Cholangiocarcinoma
- (2014) Hiroyuki Takahashi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Differences in immunohistochemical biomarkers between intra- and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
- (2014) Jimme K. Wiggers et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
- (2014) John Bridgewater et al. JOURNAL OF HEPATOLOGY
- Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo
- (2014) DONGSHENG XU et al. ONCOLOGY REPORTS
- Inhibition of Tumor Angiogenesis by Interferon-γ by Suppression of Tumor-Associated Macrophage Differentiation
- (2014) Tao Sun et al. ONCOLOGY RESEARCH
- Angiopoietin-2 and Biliary Diseases: Elevated Serum, but Not Bile Levels Are Associated with Cholangiocarcinoma
- (2014) Torsten Voigtländer et al. PLoS One
- miR-101 Inhibits Cholangiocarcinoma Angiogenesis through Targeting Vascular Endothelial Growth Factor (VEGF)
- (2013) Jinqiang Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas
- (2013) J K Lee et al. BRITISH JOURNAL OF CANCER
- Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
- (2013) Daniela Sia et al. GASTROENTEROLOGY
- Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma
- (2013) Massimiliano Cadamuro et al. HEPATOLOGY
- Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
- (2013) Do Hyung Kim et al. International Journal of Nanomedicine
- Exome sequencing identifies distinct mutational patterns in liver fluke–related and non-infection-related bile duct cancers
- (2013) Waraporn Chan-on et al. NATURE GENETICS
- CD146, a multi-functional molecule beyond adhesion
- (2012) Zhaoqing Wang et al. CANCER LETTERS
- Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
- (2012) Shahid A Khan et al. GUT
- Exome sequencing of liver fluke–associated cholangiocarcinoma
- (2012) Choon Kiat Ong et al. NATURE GENETICS
- Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma
- (2012) Sirintip Boonjaraspinyo et al. TUMOR BIOLOGY
- Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer
- (2011) Wei Lin et al. CANCER LETTERS
- Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways
- (2011) S. Prakobwong et al. CARCINOGENESIS
- A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
- (2011) Jun Ho Yi et al. EUROPEAN JOURNAL OF CANCER
- Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
- (2011) Jesper B. Andersen et al. GASTROENTEROLOGY
- Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma
- (2011) Heather Francis et al. GUT
- SWOG 0514: a phase II study of sorafenib in patients with unresectable or metastatic gallbladder carcinoma and cholangiocarcinoma
- (2011) Anthony B. El-Khoueiry et al. INVESTIGATIONAL NEW DRUGS
- Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers
- (2011) Tanios Bekaii-Saab et al. JOURNAL OF CLINICAL ONCOLOGY
- Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells
- (2011) Hiroaki Sugiyama et al. JOURNAL OF GASTROENTEROLOGY
- HCC and angiogenesis: possible targets and future directions
- (2011) Andrew X. Zhu et al. Nature Reviews Clinical Oncology
- Clinical diagnosis and staging of cholangiocarcinoma
- (2011) Boris Blechacz et al. Nature Reviews Gastroenterology & Hepatology
- Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma
- (2011) Wenjun Wang et al. TUMOR BIOLOGY
- Prognostic impact of vascular endothelial growth factor-A expression in resected gallbladder carcinoma
- (2011) Xiao-Nan Sun et al. TUMOR BIOLOGY
- Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
- (2010) Horlad Hasita et al. CANCER SCIENCE
- Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis
- (2010) Suksanti Prakobwong et al. INTERNATIONAL JOURNAL OF CANCER
- Report of a Multicenter Phase II Trial Testing a Combination of Biweekly Bevacizumab and Daily Erlotinib in Patients With Unresectable Biliary Cancer: A Phase II Consortium Study
- (2010) Sam J. Lubner et al. JOURNAL OF CLINICAL ONCOLOGY
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma
- (2009) Armin Thelen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma
- (2009) D Yoshikawa et al. BRITISH JOURNAL OF CANCER
- Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial
- (2009) C Bengala et al. BRITISH JOURNAL OF CANCER
- Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas
- (2009) Nathalie Guedj et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
- (2009) Andrew X Zhu et al. LANCET ONCOLOGY
- H3 Histamine Receptor-Mediated Activation of Protein Kinase C Inhibits the Growth of Cholangiocarcinoma In vitro and In vivo
- (2009) H. Francis et al. MOLECULAR CANCER RESEARCH
- Drug resistance associated with antiangiogenesis therapy
- (2009) Hans Petter Eikesdal et al. SEMINARS IN CANCER BIOLOGY
- Role of tumor angiogenesis in gallbladder carcinoma: with special reference to thymidine phosphorylase
- (2008) Yukari Harino et al. International Journal of Clinical Oncology
- Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma
- (2008) Armin Thelen et al. JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started